Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 6,815 full-time employees. The company went IPO on 2020-10-27. The firm's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The firm also produces various drugs, including Endostar used for oncology. The firm is also involved in providing promotion services for third-party drugs sold by medical institutions. The firm mainly conducts its businesses in the domestic market and overseas markets.
02096.HK stock price ended at $12.28 on jeudi, after dropping 3.08%
On the latest trading day Feb 12, 2026, the stock price of 02096.HK fell by 3.08%, dropping from $12.56 to $12.28. During the session, the stock saw a volatility of 3.70%, with prices oscillating between a daily low of $12.17 and a high of $12.62. On the latest trading day, the trading volume for 02096.HK rose by 316.5K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 4.6M shares were traded, with a market value of approximately $31.8B.
Signaux Techniques de 02096.HK
Résumé des Signaux Techniques
Acheter des signaux 3
Signaux neutres 1
Signaux de vente 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
02096.HK présente actuellement 3 signaux d'achat et 3 signaux de vente. L'action est en Tendance baissière depuis 12:00 AM, avec une variation totale du prix de -3.08% pendant cette période. En général, les indicateurs techniques indiquent une tendance Neutral à moyen terme.
Signaux haussiers/baissiers pour 02096.HK
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour 02096.HK, vous aidant à prendre des décisions d'investissement éclairées.